文献速递乳房整形与再造

自体与假体乳房再造的长期费用与医疗使用比较

Autologous Breast Reconstruction versus Implant-Based Reconstruction: How Do Long-Term Costs and Health Care Use Compare?
PubMed 文献 · Plast Reconstr Surg · 2020-01-01

基于美国OptumLabs保险理赔数据,纳入2004至2014年12296例即刻乳房再造女性,比较自体(4257例)与假体(8039例)再造的2年医疗使用率与预测费用。假体再造初始费用较低但医疗使用率更高,单侧手术2年总费用假体组反而更高。

要点

  • 假体再造初始手术费用低于自体再造,但2年医疗使用率更高。
  • 单侧假体再造2年总费用高于自体再造,双侧两者2年总费用相似。
  • 假体再造住院与门诊就诊率更高,急诊就诊率两组相似。

核心结论

  • 假体再造虽为更便宜的初始手术,但医疗使用率更高,导致2年总医疗费用与自体再造相似。

研究设计与样本

  • 回顾性行政理赔数据分析,使用OptumLabs Data Warehouse,纳入2004年1月至2014年12月接受即刻自体或假体乳房再造的女性,比较2年使用率与预测费用,采用t检验。

主要发现

  • 共识别12296例即刻乳房再造,自体4257例(35%),假体8039例(65%)。
  • 自体再造比例从2004年47.2%降至2014年32.7%。
  • 单侧和双侧手术中,自体再造的平均预测再造费用均高于假体再造。
  • 双侧手术中,两种方法平均预测2年医疗费用相似;单侧手术中,假体再造2年总费用高于自体再造。
  • 单侧假体再造较自体再造住院率(30.3 vs 23.1/100;p<0.01)和门诊就诊率(2445.1 vs 2283.6/100;p<0.01)更高,急诊就诊率相似;双侧结果类似。

临床怎么用

  • 评估乳房再造方式时,除初始手术费用外,应综合考虑2年医疗使用与总费用。
  • 假体再造需关注更高的住院和门诊就诊负担,尤其单侧手术。

局限性

  • 基于美国单一保险计划行政理赔数据的回顾性分析,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The authors compared long-term health care use and cost in women undergoing immediate autologous breast reconstruction and implant-based breast reconstruction. METHODS: This study was conducted using the OptumLabs Data Warehouse, which contains deidentified retrospective administrative claims data, including medical claims and eligibility information from a large U.S. health insurance plan. Women who underwent autologous or implant-based breast reconstruction between January of 2004 and December of 2014 were included. The authors compared 2-year use rates and predicted costs of care. Comparisons were tested using the t test. RESULTS: Overall, 12,296 women with immediate breast reconstruction were identified; 4257 with autologous (35 percent) and 8039 with implant-based (65 percent) breast reconstruction. The proportion of autologous breast reconstruction decreased from 47.2 percent in 2004 to 32.7 percent in 2014. The mean predicted reconstruction cost of autologous reconstruction was higher than that of implant-based reconstruction in both unilateral and bilateral surgery. Similar results for mean predicted 2-year cost of care were seen in bilateral procedures. However, in unilateral procedures, the 2-year total costs were higher for implant-based than for autologous reconstruction. Two-year health care use rates were higher for implant-based reconstruction than for autologous reconstruction for both unilateral and bilateral procedures. Women undergoing unilateral implant-based reconstruction had higher rates of hospital admissions (30.3 versus 23.1 per 100; p < 0.01) and office visits (2445.1 versus 2283.6 per 100; p < 0.01) than those who underwent autologous reconstruction. Emergency room visit rates were similar between the two methods. Bilateral procedures yielded similar results. CONCLUSION: Although implant-based breast reconstruction is a less expensive index operation than autologous breast reconstruction, it was associated with higher health care use, resulting in similar total cost of care over 2 years.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Lemaine V, Schilz SR, Van Houten HK, et al. Autologous Breast Reconstruction versus Implant-Based Reconstruction: How Do Long-Term Costs and Health Care Use Compare? Plast Reconstr Surg. 2020. PMID: 31985608. doi:10.1097/PRS.0000000000006422

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。